» Articles » PMID: 37446758

Photodynamic Therapy: From the Basics to the Current Progress of -Heterocyclic-Bearing Dyes As Effective Photosensitizers

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2023 Jul 14
PMID 37446758
Authors
Affiliations
Soon will be listed here.
Abstract

Photodynamic therapy, an alternative that has gained weight and popularity compared to current conventional therapies in the treatment of cancer, is a minimally invasive therapeutic strategy that generally results from the simultaneous action of three factors: a molecule with high sensitivity to light, the photosensitizer, molecular oxygen in the triplet state, and light energy. There is much to be said about each of these three elements; however, the efficacy of the photosensitizer is the most determining factor for the success of this therapeutic modality. Porphyrins, chlorins, phthalocyanines, boron-dipyrromethenes, and cyanines are some of the -heterocycle-bearing dyes' classes with high biological promise. In this review, a concise approach is taken to these and other families of potential photosensitizers and the molecular modifications that have recently appeared in the literature within the scope of their photodynamic application, as well as how these compounds and their formulations may eventually overcome the deficiencies of the molecules currently clinically used and revolutionize the therapies to eradicate or delay the growth of tumor cells.

Citing Articles

Exploring the potential of 7,4'-di(diethylamino)flavylium as a novel photosensitizer for topical photodynamic therapy of skin cancer.

Correia P, Araujo P, Marto J, Ribeiro H, Mateus N, de Freitas V Sci Rep. 2024; 14(1):29535.

PMID: 39604502 PMC: 11603071. DOI: 10.1038/s41598-024-80860-x.


Liposomal Formulations of Novel BODIPY Dimers as Promising Photosensitizers for Antibacterial and Anticancer Treatment.

Porolnik W, Ratajczak M, Mackowiak A, Murias M, Kucinska M, Piskorz J Molecules. 2024; 29(22).

PMID: 39598693 PMC: 11596046. DOI: 10.3390/molecules29225304.


Recent progress in hematoporphyrin monomethyl ether-photodynamic therapy for port-wine stains: updates and insights.

Khalaf A, Wei Y, Abdalla A, Fan W, Jiang H Arch Dermatol Res. 2024; 317(1):28.

PMID: 39549139 DOI: 10.1007/s00403-024-03531-x.


Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma.

Aebisher D, Woznicki P, Czarnecka-Czapczynska M, Dynarowicz K, Szliszka E, Kawczyk-Krupka A Int J Mol Sci. 2024; 25(16).

PMID: 39201395 PMC: 11354549. DOI: 10.3390/ijms25168708.


Evaluating the potency of laser-activated antimicrobial photodynamic therapy utilizing methylene blue as a treatment approach for chronic periodontitis.

Perumal M, Renuka R, Natarajan P Front Oral Health. 2024; 5:1407201.

PMID: 38872983 PMC: 11169725. DOI: 10.3389/froh.2024.1407201.


References
1.
Balalaeva I, Mishchenko T, Turubanova V, Peskova N, Shilyagina N, Plekhanov V . Cyanoarylporphyrazines with High Viscosity Sensitivity: A Step towards Dosimetry-Assisted Photodynamic Cancer Treatment. Molecules. 2021; 26(19). PMC: 8510116. DOI: 10.3390/molecules26195816. View

2.
Ranson M . Epidermal growth factor receptor tyrosine kinase inhibitors. Br J Cancer. 2004; 90(12):2250-5. PMC: 2410290. DOI: 10.1038/sj.bjc.6601873. View

3.
De Crevoisier R, Lafond C, Mervoyer A, Hulot C, Jaksic N, Bessieres I . Image-guided radiotherapy. Cancer Radiother. 2021; 26(1-2):34-49. DOI: 10.1016/j.canrad.2021.08.002. View

4.
Delaey E, van Laar F, De Vos D, Kamuhabwa A, Jacobs P, DE Witte P . A comparative study of the photosensitizing characteristics of some cyanine dyes. J Photochem Photobiol B. 2000; 55(1):27-36. DOI: 10.1016/s1011-1344(00)00021-x. View

5.
Brilkina A, Dubasova L, Sergeeva E, Pospelov A, Shilyagina N, Shakhova N . Photobiological properties of phthalocyanine photosensitizers Photosens, Holosens and Phthalosens: A comparative in vitro analysis. J Photochem Photobiol B. 2019; 191:128-134. DOI: 10.1016/j.jphotobiol.2018.12.020. View